Janice L Gabrilove MD

Oncology•New York, NY

Hematologic Oncology

Professor of Medicine, Mount Sinai School of Medicine

Request appointment

1190 5th Avenue Guggenheim PavillMount Sinai Hospitalruttenberg Treatment CenterNew York, NY 10029
Book by Phone+1(747) 758-4988
Fax+1 212-423-0522

Overview of Dr. Gabrilove

Janice L. Gabrilove, M.D., is a world-renowned expert on the role of hematopoietic growth factors in normal and malignant hematopoiesis; and the role of these cytokines in ameliorating disease and treatment-related myelosuppression. She previously served on the faculty at Memorial Sloan-Kettering Cancer Center, where she rose to the rank of Associate Professor of Medicine. In 1998, she was recruited to The Mount Sinai School of Medicine as The James F. Holland Professor of Medicine, and Chief of the Division of Medical Oncology. She presently serves as the Associate Director, Education & Training for the Tisch Cancer Institute, an NCI-Designated Cancer Center at the Icahn School of Medicine at Mount Sinai. She also serves as the Director of the Clinical Research Education Program out of the Graduate School of Biomedical Sciences and oversees the Certificate, Masters of Science (MSCR) and PhD in Clinical Research.

Dr. Gabrilove is the recipient of a composition of matter and use patent for the discovery of human granulocyte colony stimulating factor (G-CSF), and was the first to demonstrate that it could alleviate certain harmful effects of chemotherapy on blood-cell production. G-CSF, now produced commercially by Amgen, Inc. under the trade-name Neupogen & Neulasta, is used worldwide as a supplement to chemotherapy. Dr. Gabrilove was the first to report on the ability of G-CSF to mobilize progenitors into the peripheral blood, an observation which has revolutionized the way in which bone-marrow transplantation is performed with the development of peripheral blood stem-cell transplants. Dr. Gabrilove has been awarded two additional patents for novel therapeutics fostering leukemic cell maturation, currently approved by the FDA, for the treatment of acute promyelocytic leukemia (APL).

Dr. Gabrilove is the recipient of numerous awards and presently holds 4 patents related to her work. She is a member of the American Society of Clinical Investigation

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1980 - 1984
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1977 - 1980
Icahn School of Medicine at Mount SinaiClass of 1977
Goucher CollegeB.A., 1969 - 1973

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2020 - Present
NY State Medical License 1979 - 2028
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Fellow American College of Physicians, 2013
Top Doctors: New York Metro Area Castle Connolly
America's Top Doctors for Cancer Castle Connolly, 2005-2017

Publications & Presentations

PubMed

Factors Associated with Burnout, Low Professional Fulfillment, and Intention to Leave Among Biomedical Research Faculty.
Lauren Peccoralo, Robert H Pietrzak, Jonathan Ripp, Uraina S Clark, Nihal E Mohamed
Journal of Occupational and Environmental Medicine. 2026-05-22
Expedited diagnosis of disseminatedinfection using targeted (amplicon-based) next-generation sequencing in an immunocompromised patient.
Risa Fuller, Bruce E Petersen, Shafinaz Hussein, Christian Salib, Amy Duffield
ASM Case Reports. 2025-11-01
2 citations
Design and implementation of a Targeted HealthcaRe InnoVation & Entrepreneurship (THRIVE) fellowship program.
Ian C Odland, Joseph Borrello, Layla Fattah, Tyree D Williams, Kevin D Costa
Plos One. 2025-01-01

Journal Articles

The Mentored-to-Independent Transition: Survey of Clinical and Translational Education and Career Development Leaders
Sweeney CS, Schwartz LS, Toto R, Fair A, Ahluwalia JS., Gabrilove JL, Acad Med, 1/1/2016
Sustaining the Clinical Translational Research Workforce: Training and Empowering
Yin HL, Gabrilove J, Jackson, Rebecca, Sweeney, C, Fair A, Toto R, Acad Med, 1/1/2015
Understanding Career Success and Contributing Factors for Clinical and Translational Investigators
Georgeanna FWB Robinson, EdD, Lisa S Schwartz, EdD, MS, Linda A DiMeglio, MD, MPH, Jasjit S Ahluwalia, MD, MPH, Janice L Gabrilove, MD, Academic Medicine, 1/1/2015

Books/Book Chapters

Filgrastim in Clinical Practice
Chapter: Filgrastim in lymphoma
Gabrilove JL, Moskowitz, Craig. HEditors: Morstyn G, Dexter M.Marcel Dekker1997
Cytokines in the treatment of hematopoietic failure
Chapter: Hematopoietic growth factors in leukemia
Gabrilove JLEditors: Ganser A, Hoelzer.Marcel Dekker1997
Neoplastic Diseases of the Blood
Chapter: Hematopoietic growth factors
Gabrilove JLEditors: Wiernik PH, Kyle RA, Dutcher JP.Churchill Livingstone, New York CityEdition 3rd,1995

Abstracts/Posters

Hyperlipidemia, carotenoderma, and respiratory failure: An unusual initial presentation of multiple myeloma
N. Carreau, N. Siegel, S. Saul, J. Gabrilove, K.S. Mathews, CHEST, 1/1/2015
Factors that Facilitate or Hinder Transition to Independence for Clinical and Translational Researchers: A Qualitative Research Study
Robinson GFWB, Schwartz LA, DiMeglio LA, Ahluwalia JS, Gabrilove JL, SCTS/ACRT Annual Meeting, 1/1/2014
The Mentored to Independent Transition: Survey of CTSA Education and Career Development (EDCD) Leaders
Sweeney C, Schwartz L, Toto, R, Gabrilove JL, SCTS/ACRT Meeting, 1/1/2014

Lectures

Biology and clinical application of human granulocyte colony stimulating factor
Staten Island University Hospital, Staten Island, NY - 1/20/2005
The Biology and Management of MDS
Union Hospital, NJ, 2004; Great Neck, NY, 2005 - 1/15/2005
The Biology and Management of the Anemia of Cancer
Multiple Locations, 2002, 2003, 2004 - 1/10/2005

Grant Support

TCI Mentored Medical Student Summer Scholars (TCI-MMSSS) ProgramICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2023–2028
The Tisch Cancer Institute (TCI) Paul Calabresi K12 Career Development Award for Clinical OncologyICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2022–2027
J: NRSA Training CoreICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2022–2027
Strategic Curriculum For Clinical ResearchNational Center For Research Resources2005–2009
BP1 And Nuclear Hormone Signaling In Breast CancerNational Cancer Institute2006–2007

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
Alpha Omega Alpha Honor Medical Society - AOA
Member
American Society of Hematology - ASH
Member
American Association for Cancer Research - AACR
Member
American Society of Clinical Investigation
Member

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPO
MagnaCare PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment